National Medicines Institute, 00-725 Warsaw, Poland.
Institute of Organic Chemistry, Polish Academy of Sciences, 01-224 Warsaw, Poland.
Int J Mol Sci. 2021 Jul 12;22(14):7471. doi: 10.3390/ijms22147471.
The compounds 7-ethyl-9-(-methylamino)methyl-10-hydroxycamptothecin () and 7-ethyl-9-(-morpholino)methyl-10-hydroxycamptothecin () are potential topoisomerase I poisons. Moreover, they were shown to have favorable anti-neoplastic effects on several tumor cell lines. Due to these properties, the compounds are being considered for advancement to the preclinical development stage. To gain better insights into the molecular mechanism with the biological target, here, we conducted an investigation into their interactions with model nicked DNA () using different techniques. In this work, we observed the complexity of the mechanism of action of the compounds and , in addition to their decomposition products: compound and SN38. Using DOSY experiments, evidence of the formation of strongly bonded molecular complexes of SN38 derivatives with DNA duplexes was provided. The molecular modeling based on cross-peaks from the NOESY spectrum also allowed us to assign the geometry of a molecular complex of DNA with compound . Confirmation of the alkylation reaction of both compounds was obtained using MALDI-MS. Additionally, in the case of , alkylation was confirmed in the recording of cross-peaks in the H/C HSQC spectrum of C-enriched compound In this work, we showed that the studied compounds-parent compounds and , and their potential metabolite and SN38-interact inside the nick of , either forming the molecular complex or alkylating the DNA nitrogen bases. In order to confirm the influence of the studied compounds on the topoisomerase I relaxation activity of supercoiled DNA, the test was performed based upon the measurement of the fluorescence of DNA stain which can differentiate between supercoiled and relaxed DNA. The presented results confirmed that studied SN38 derivatives effectively block DNA relaxation mediated by Topo I, which means that they stop the machinery of Topo I activity.
化合物 7-乙基-9-(-甲氨基)甲基-10-羟基喜树碱()和 7-乙基-9-(-吗啉基)甲基-10-羟基喜树碱()是潜在的拓扑异构酶 I 抑制剂。此外,它们对几种肿瘤细胞系表现出良好的抗肿瘤作用。由于这些特性,这些化合物正在被考虑推进到临床前开发阶段。为了更深入地了解与生物靶标的分子机制,我们在这里使用不同的技术研究了它们与模型切口 DNA()的相互作用。在这项工作中,我们观察到化合物和它们的分解产物:化合物和 SN38 的作用机制的复杂性。使用 DOSY 实验,提供了 SN38 衍生物与 DNA 双链形成强结合分子复合物的证据。基于来自 NOESY 光谱的交峰的分子建模还允许我们分配与化合物形成的分子复合物的 DNA 几何形状。使用 MALDI-MS 获得了对两种化合物的烷基化反应的确认。此外,在化合物的情况下,通过在 C 富集化合物的 H/C HSQC 光谱中记录的交叉峰的方式确认了烷基化。在这项工作中,我们表明,所研究的化合物-母体化合物和,以及它们的潜在代谢物和 SN38-在切口内相互作用,要么形成分子复合物,要么烷基化 DNA 氮碱基。为了确认所研究的化合物对超螺旋 DNA 的拓扑异构酶 I 松弛活性的影响,根据可以区分超螺旋和松弛 DNA 的 DNA 染色剂的荧光测量进行了测试。所呈现的结果证实,所研究的 SN38 衍生物有效地阻断了 Topo I 介导的 DNA 松弛,这意味着它们阻止了 Topo I 活性的机制。